Every material Form 8-K Jackson Acquisition Co II has filed with the SEC since December 17, 2024, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Jackson Acquisition Company II said it received a notice from the New York Stock Exchange on February 6, 2026, stating that it does not meet the NYSE requirement to maintain at least 300 public stockholders on a continuous basis. The company must submit a business plan within 45 days of receiving the notice showing how it will return to compliance within 18 months, and the NYSE then has 45 days to review it.
NYSE notice received February 6, 2026, citing Section 802.01B of the NYSE Listed Company Manual
Company must submit a business plan within 45 days of receipt, showing compliance within 18 months
Notice has no immediate effect on listing or trading; shares stay listed under JACS if the NYSE approves the plan
If the plan fails or is not accepted, the NYSE may start suspension and delisting procedures
Jackson Acquisition Company II said that, starting January 30, 2025, holders of units sold in its December 11, 2024 initial public offering can separate them and trade the Class A ordinary shares and rights individually on the NYSE. The change is administrative and does not alter the rights' terms, which entitle holders to one-tenth of a Class A ordinary share upon completion of an initial business combination.
Units sold in the December 11, 2024 initial public offering can be separated starting January 30, 2025
Separated shares and rights will trade on the NYSE as JACS and JACS.R; units not separated keep trading as JACS.U
Each unit consists of one Class A ordinary share and one right to receive one-tenth of a Class A ordinary share upon an initial business combination
Holders must have their brokers contact Continental Stock Transfer & Trust Company, the transfer agent, to separate units
Jackson Acquisition Company II, a blank check company focused on healthcare, closed its initial public offering on December 11, 2024, including the full exercise of the underwriter's over-allotment option. The company placed $232.3 million in a trust account, and it has 24 months from the IPO closing to complete a business combination or redeem public shares.
Sold 23,000,000 units at $10.00 each for gross proceeds of $230 million, including 3,000,000 over-allotment units.
Sold 840,000 private placement units for $8.4 million to RJ Healthcare SPAC II, LLC and Roth Capital Partners, LLC.
Placed $232.3 million in a trust account with Continental Stock Transfer & Trust Company, or $10.10 per Unit.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Jackson Acquisition Co II filing is on SEC EDGAR ↗. 8-K briefs of other companies →